Showing posts with label ondansetron. Show all posts
Showing posts with label ondansetron. Show all posts
Wednesday, April 25, 2012
Current Drug Shortages: Ondansetron Injection 2 mg/mL (updated)
Current Drug Shortages: Ondansetron Injection 2 mg/mL (updated):
APP has Ondansetron 2 mg/mL 2 mL vials on back order with an estimated release date of early May 2012. Check wholesalers for inventory. The 40 mg, 20mL vials are on back-order until late May.
add your opinions
drug shortages
,
ondansetron
Tuesday, March 13, 2012
Monday, February 20, 2012
2011 National Guideline Clearinghouse | Antiemetics (nausea): American Society of Clinical Oncology clinical practice guideline update.
also note:
FDA Warning/Regulatory Alert
Note from the National Guideline Clearinghouse: This guideline references a drug(s) for which important revised regulatory and/or warning information has been released.
- September 15, 2011 – Zofran (ondansetron) : The U.S. Food and Drug Administration (FDA) notified healthcare professionals and patients of an ongoing safety review and labeling changes for the anti-nausea drug Zofran (ondansetron, ondansetron hydrochloride and generics). Ondansetron may increase the risk of developing prolongation of the QT interval of the electrocardiogram, which can lead to an abnormal and potentially fatal heart rhythm, including Torsade de Pointes.
add your opinions
chemotherapy induced nausea
,
clinical practice guidelines
,
ondansetron
,
zofran
Monday, June 07, 2010
Medical News: ondansetron - Cancer Antiemetic Recalled By Drugmaker - in Product Alert, Prescriptions from MedPage Today
Cancer Antiemetic Recalled By Drugmaker
By Cole Petrochko, Staff Writer, MedPage Today
Published: June 07, 2010
The distributor of intravenous ondansetron for use in preventing nausea and vomiting in patients undergoing chemotherapy initiated a voluntary recall due to debris and possible contamination of lots of the product.
Nonsterile bags of the treatment may result in potentially fatal infections, particularly in immunocompromised patients.
Affected lot numbers include A090309 through A090312. The pouches were distributed from August 2009 to May 2010.....
add your opinions
contamination
,
nausea
,
ondansetron
,
vomiting
Subscribe to:
Posts
(
Atom
)